Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate F Walker

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Health Technology Assessment (Winchester, England)|August 18, 2025
Glycaemic control in labour with diabetes: GILD, a scoping studyNia Wyn Jones, Eleanor J Mitchell, Kate F Walker, et al.
F1000Research|August 29, 2024
GBS vaccines in the UK: a round table discussionNatasha Thorn, Rebecca L Guy, Konstantinos Karampatsas, et al.
Trials|January 21, 2022
The FEED1 trial: protocol for a randomised controlled trial of full milk feeds versus intravenous fluids with gradual feeding for preterm infants (30-33 weeks gestational age)Eleanor J Mitchell, Garry Meakin, Josie Anderson, et al.
The Lancet. Child & Adolescent Health|October 20, 2025
Full exclusively enteral fluids from day 1 versus gradual feeding in preterm infants (FEED1): a open-label, parallel-group, multicentre, randomised, superiority trialShalini Ojha, Eleanor J Mitchell, Mark J Johnson, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|December 21, 2025
Cost-consequence analysis of early full milk feeding versus gradual feeding with intravenous support in preterm infants: results from the FEED1 trialSeyran Naghdi, Shalini Ojha, Jon Dorling, et al.
Lancet (London, England)|March 6, 2025
Atosiban versus placebo for threatened preterm birth (APOSTEL 8): a multicentre, randomised controlled trialLarissa I van der Windt, Job Klumper, Ruben G Duijnhoven, et al.
The Lancet. Global Health|March 22, 2026
Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate-to-severe postpartum anaemia in Nigerian women (IVON-PP): an open-label, randomised controlled trialBosede B Afolabi, Victoria O Adaramoye, Titilope A Adeyemo, et al.
Early Human Development|March 2, 2026
Corrigendum to "Universal maternal testing for group B streptococcus in late pregnancy: process outcomes and alongside qualitative study for the GBS3 trial" [Early Hum. Dev. 213 (2026) Page 1-5/P106442]Jane P Daniels, Kate F Walker, Lucy Bradshaw, et al.
Early Human Development|December 1, 2025
Universal maternal testing for group B streptococcus in late pregnancy: process outcomes and alongside qualitative study for the GBS3 trialJane P Daniels, Kate F Walker, Lucy Bradshaw, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Health Technology Assessment (Winchester, England)|August 18, 2025
Glycaemic control in labour with diabetes: GILD, a scoping studyNia Wyn Jones, Eleanor J Mitchell, Kate F Walker, et al.
F1000Research|August 29, 2024
GBS vaccines in the UK: a round table discussionNatasha Thorn, Rebecca L Guy, Konstantinos Karampatsas, et al.
Trials|January 21, 2022
The FEED1 trial: protocol for a randomised controlled trial of full milk feeds versus intravenous fluids with gradual feeding for preterm infants (30-33 weeks gestational age)Eleanor J Mitchell, Garry Meakin, Josie Anderson, et al.
The Lancet. Child & Adolescent Health|October 20, 2025
Full exclusively enteral fluids from day 1 versus gradual feeding in preterm infants (FEED1): a open-label, parallel-group, multicentre, randomised, superiority trialShalini Ojha, Eleanor J Mitchell, Mark J Johnson, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|December 21, 2025
Cost-consequence analysis of early full milk feeding versus gradual feeding with intravenous support in preterm infants: results from the FEED1 trialSeyran Naghdi, Shalini Ojha, Jon Dorling, et al.
Lancet (London, England)|March 6, 2025
Atosiban versus placebo for threatened preterm birth (APOSTEL 8): a multicentre, randomised controlled trialLarissa I van der Windt, Job Klumper, Ruben G Duijnhoven, et al.
The Lancet. Global Health|March 22, 2026
Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate-to-severe postpartum anaemia in Nigerian women (IVON-PP): an open-label, randomised controlled trialBosede B Afolabi, Victoria O Adaramoye, Titilope A Adeyemo, et al.
Early Human Development|March 2, 2026
Corrigendum to "Universal maternal testing for group B streptococcus in late pregnancy: process outcomes and alongside qualitative study for the GBS3 trial" [Early Hum. Dev. 213 (2026) Page 1-5/P106442]Jane P Daniels, Kate F Walker, Lucy Bradshaw, et al.
Early Human Development|December 1, 2025
Universal maternal testing for group B streptococcus in late pregnancy: process outcomes and alongside qualitative study for the GBS3 trialJane P Daniels, Kate F Walker, Lucy Bradshaw, et al.
Pageof 6